Latest Healthcare News

Page 11 of 149
Island Pharmaceuticals has secured over $1 million through option exercises by directors and major shareholders, bolstering its cash reserves to advance the clinical and regulatory development of its broad-spectrum antiviral, Galidesivir.
Ada Torres
Ada Torres
3 Dec 2025
Optiscan Imaging Ltd has initiated Australia’s first intra-operative head and neck cancer imaging study using its advanced InVue® and InForm™ devices, aiming to enhance surgical precision and support FDA regulatory submissions.
Ada Torres
Ada Torres
3 Dec 2025
BCAL Diagnostics has secured national ethics approval to establish a large-scale registry tracking the clinical impact of its BREASTESTplus blood test for breast cancer diagnosis, aiming to enhance doctor adoption and reimbursement prospects.
Ada Torres
Ada Torres
3 Dec 2025
Biotron Limited has completed a $1 million placement to fund the development of its newly acquired Sedarex Limited assets, marking a strategic expansion of its antiviral portfolio.
Ada Torres
Ada Torres
2 Dec 2025
Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.
Ada Torres
Ada Torres
2 Dec 2025
Vitasora Health has secured AU$3.56 million from a cornerstone investor, issuing over 118 million shares, while confirming compliance with key regulatory disclosure obligations.
Ada Torres
Ada Torres
2 Dec 2025
Immutep Limited reveals promising Phase II results from its AIPAC-003 trial, establishing 30 mg as the optimal biological dose of eftilagimod alfa combined with paclitaxel in metastatic breast cancer patients.
Ada Torres
Ada Torres
2 Dec 2025
Imagion Biosystems is set to submit its Investigational New Drug application for the MagSense® HER2 breast cancer imaging agent in December 2025, paving the way for a Phase 2 clinical trial in early 2026. Collaboration with Wayne State University has refined the trial design, promising improved patient safety and diagnostic precision.
Ada Torres
Ada Torres
1 Dec 2025
Healius Limited has landed a significant five-year contract to provide pathology services to the Australian Defence Force, leveraging its national network and digital health solutions.
Ada Torres
Ada Torres
1 Dec 2025
Paragon Care Limited is set to acquire Indonesian medical aesthetics leader Haju Medical for A$70 million, aiming to boost its footprint across Asia Pacific and accelerate growth in the aesthetics sector.
Ada Torres
Ada Torres
1 Dec 2025
Pro Medicus Limited’s U.S. subsidiary has landed a $25 million, seven-year contract to deploy its cloud-based Visage 7 Open Archive with BayCare, extending an existing partnership and marking a significant step in its North American growth.
Ada Torres
Ada Torres
1 Dec 2025
Papyrus Australia reported a $112k net operating cash outflow in October 2025, offset by financing activities and R&D tax incentives, maintaining a runway of over five months. Despite a non-recurring legal expense and an investment write-down, the company remains confident in its operational continuity.
Ada Torres
Ada Torres
28 Nov 2025